Snoop 0.05% nasal spray 15ml vials. p / e with the crucified.

$2.93

Snoop 0.05% nasal spray 15ml vials. p / e with the crucified.

Quantity:

SKU: 0338862395 Categories: , , Tags: ,

Description

Composition
Active substance:
1 g spray comprising Xylometazoline hydrochloride 0.5 mg or 1.0 mg.
Excipients:
Seawater – 250.0 mg Potassium dihydrogen phosphate – 0.45 mg Purified Water – 754.35 mg or 753.85 mg.
Description:
A colorless, transparent solution.
Product form:
Nasal Spray 0.05% and 0.1%. 15 ml of a nasal spray (150 doses) in a plastic bottle with a spray valve (3K system). 1 bottle with instructions for medical use of the drug is placed in a cardboard pack.
Contraindications
Hypersensitivity, arterial hypertension, tachycardia, expressed atherosclerosis, glaucoma, atrophic rhinitis, thyrotoxicosis, surgical interventions in the meninges (history), pregnancy, children under 6 years (for a 0.1% solution), children under 2 years (for 0.05% solution).
Diabetes, severe cardiovascular disease (including coronary heart disease), prostatic hypertrophy, pheochromocytoma, porphyria, hyperthyroidism, lactation, simultaneous monoamine oxidase inhibitors, tricyclic antidepressants, and other medications that improve blood pressure; hypersensitivity to adrenergic drugs accompanied by insomnia, dizziness, arrhythmia, tremor, increased blood pressure.
Dosage
0.5 mg / ml
Indications
Acute respiratory illness with symptoms of rhinitis (common cold), acute allergic rhinitis, hay fever, sinusitis, evstahiit, otitis media (to minimize swelling of nasal mucosa) to facilitate rinoskopii and other diagnostic procedures in the nasal passages.
Interaction with other drugs
Incompatible with MAO inhibitors and tricyclic antidepressants.
Overdose
Symptoms: increased side effects.
Treatment is symptomatic, under the supervision of a physician.
pharmachologic effect
Pharmacological group:
Decongestant agent.
Pharmacological properties:
Xylometazoline refers to a group of local vasoconstrictors with alpha Adrenomimeticalkie activity causes vasoconstriction of nasal mucosa, eliminating edema and hyperemia of the nasal mucosa, nasal restores patency, easier nasal breathing.
Effect of the drug occurs within minutes after application and lasts for several hours.
Pharmacokinetics:
When applied topically, the drug is practically not absorbed, however, its concentration in the blood plasma is very low (modern analytical methods not determined).
Conditions of supply of pharmacies
Without a prescription.
side effects
With frequent and / or prolonged use – irritation and / or dryness of the nasal mucosa, burning, crawling, sneezing, hypersecretion.
Rarely – swelling of nasal mucosa, palpitation, tachycardia, arrhythmia, hypertension, headache, vomiting, insomnia, blurred vision; depression (with prolonged use at high doses).
special instructions
It should not be used for a long time, for example in chronic rhinitis.
Seawater, which is part of the preparation, contributes to the maintenance of normal physiological condition of the oral mucosa of the nose due to the ability to improve the function of the ciliated epithelium and mucus production in the normalization mucosal goblet cells.
Effects on ability to drive vehicles and mechanisms
Subject to xylometazoline dosage regimen does not affect the concentration of attention and speed of psychomotor reactions.
Storage conditions
At temperatures above 25 ° C.
After opening the bottle the drug should be used within 12 months.
Keep out of the reach of children.
Dosing and Administration
Snup® nasal spray 0.05%
Children aged 2 to 6 years, 1 injection into each nostril (if necessary can be repeated), up to three times a day.
Adults and children from 6 years to 2 injections in each nostril up to three times a day.
Snup® nasal spray 0.1%
Adults and children from 6 years 1 injection into each nostril (can be repeated if necessary), up to three times a day.
Snup® nasal spray 0.1% should not be used in children under 6 years.
The drug should not be used more than 3 times a day, the course duration is not more than 7 days.
Before use, clean the nasal passages.
Remove the protective cap. Before the first use several times to press the rim of the nozzle (Fig. 1) until a uniform cloud “fog”. Vial is ready for further use
When applying the nozzle to enter into the nasal cavity and pressed once (Fig. 2) on the rim. The vial held upright. Do not spray horizontally or downwards. Immediately after the injection is recommended for easy inhale nose. After use, close the bottle screw cap.
Each vial should be used individually.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

STADA

There are no reviews yet.

Add your review